Ning Zu
Impact in
-
- Diabetes Treatment and Management
- Rheumatology top 10%
- Eosinophilic Disorders and Syndromes
Papers in
-
- Metabolism, Diabetes, and Cancer 4
-
- Inflammatory Myopathies and Dermatomyositis 5
- Co-authors
- Guochun Wang (3 shared papers)Lu Zhang (2 shared papers)Li Ma (2 shared papers)Freddy G. Eliaschewitz (3 shared papers)Ming Liu (3 shared papers)Yuewen Gong (2 shared papers)Yufeng Li (2 shared papers)Soo Lim (2 shared papers)
- Journals
- Diabetes Obesity and Metabolism (3 papers)Clinical Rheumatology (3 papers)The Journal of Rheumatology (1 paper)Biochemistry and Cell Biology (1 paper)Clinical Cardiology (1 paper)
- Partner nations
- ChinaDenmarkSouth Korea
In The Last Decade
Ning Zu
17 papers receiving 438 citations
Ning Zu's Hit Papers
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 127
- Rheumatology 98
- Epidemiology 198
- Pharmacology 63
- Dermatology 28
Countries citing papers authored by Ning Zu
This map shows the geographic impact of Ning Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Zu more than expected).
Fields of papers citing papers by Ning Zu
This network shows the impact of papers produced by Ning Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Zu. The network helps show where Ning Zu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 129 | |
| 2 | 2020 | 71 | |
| 3 | Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial Hit paper breakdown → | 2024 | 59 |
| 4 | 2012 | 47 | |
| 5 | 2012 | 30 | |
| 6 | 2013 | 29 | |
| 7 | 2005 | 26 | |
| 8 | 2005 | 15 | |
| 9 | 2007 | 14 | |
| 10 | 2013 | 10 | |
| 11 | 2024 | 3 | |
| 12 | 2025 | 2 | |
| 13 | [The expression of the type I interferon system in muscle and lung of autoimmune myositis rat model]. | 2011 | 2 |
| 14 | 2020 | 2 | |
| 15 | Orexin A influence progesterone secreted and the content of cAMP in sheep ovarian granulosa cells. | 2017 | 1 |
| 16 | 2017 | 1 | |
| 17 | 2017 | 1 |
About Ning Zu
Ning Zu is a scholar working on Molecular Biology, Epidemiology, Endocrinology, Diabetes and Metabolism, Rheumatology and Pharmacology, having authored 17 papers that have together received 442 indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (5 papers), Diabetes Treatment and Management (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Impact of Technology on Adolescents (2 papers), Education and Communication Studies (2 papers), Pharmacology and Obesity Treatment (2 papers) and Technology-Enhanced Education Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (127 citations), Rheumatology (98 citations), Epidemiology (198 citations), Pharmacology (63 citations) and Dermatology (28 citations). Ning Zu has collaborated with scholars based in China, Denmark and South Korea. Frequent co-authors include Guochun Wang, Lu Zhang, Li Ma, Freddy G. Eliaschewitz, Ming Liu, Yuewen Gong, Yufeng Li, Soo Lim, Li Ma and Linong Ji. Their work appears in journals such as Diabetes Obesity and Metabolism, Clinical Rheumatology, The Journal of Rheumatology, Biochemistry and Cell Biology and Clinical Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.